Research Article
25-Hydroxyvitamin D and Severity of Parkinson’s Disease
Table 2
Summery results of multiple linear regression model to UPDRS III.
| | Variables | UPDRS III | | (95% Cl) | value |
| | Age (years) | 0.39 (0.14, 0.64) | 0.002 | | Sex (M/F) | −5.05 (−12.1, 1.98) | 0.15 | | Disease duration (months) | 0.09 (0.03, 0.15) | 0.003 | | 25OHD (ng/mL) | −0.14 (−0.36, 0.06) | 0.16 | | Calcium (mg/dL) | −1.28 (−8.96, 6.39) | 0.74 | | Phosphorus (mg/dL) | 18.57 (0.97, 36.18) | 0.03 | | ALP (IU/L) | 0.06 (0.01, 0.11) | 0.008 | | PTH (ng/mL) | 0.07 (−0.08, 0.23) | 0.37 |
|
|
UPDRSIII: unified Parkinson’s disease rating stage part III motor; ALP: alkaline phosphates; PTH: parathyroid hormone; 25OHD: 25-hydroxyvitamin D; : regression coefficient; CI: confidence interval.
|
